mirage

Targeting FK506 binding proteins to fight malarial and bacterial infections : current advances and future perspectives

DSpace/Manakin Repository

 

Search DR-NTU


Advanced Search Subject Search

Browse

My Account

Targeting FK506 binding proteins to fight malarial and bacterial infections : current advances and future perspectives

Show simple item record

dc.contributor.author Bharatham, Nagakumar
dc.contributor.author Chang, M. W.
dc.contributor.author Yoon, Ho Sup
dc.date.accessioned 2012-10-09T04:08:46Z
dc.date.available 2012-10-09T04:08:46Z
dc.date.copyright 2011
dc.date.issued 2012-10-09
dc.identifier.citation Bharatham, N., Chang, M. W., & Yoon, H. S. (2011). Targeting FK506 binding proteins to fight malarial and bacterial infections: current advances and future perspectives. Current Medicinal Chemistry, 18(12), 1874-1889.
dc.identifier.issn 09298673
dc.identifier.uri http://hdl.handle.net/10220/8732
dc.description.abstract There is an urgent need for the design and development of new and selective drugs for the treatment of malaria and bacterial infections as these pathogens are developing resistance to presently available therapies. Malaria is a life threatening disease in many countries and responsible for almost one million deaths annually. In particular, drug-resistant malarial parasites are hindering effective control of malaria and prompting to find novel druggable targets and develop compounds with mechanism of action different from the conventional drugs. In this quest, efforts were made to determine three-dimensional structures of Plasmodium falciparum and Plasmodium vivax FK506 binding proteins which bind the macrolides (FK506 and rapamycin) and also demonstrate peptidylprolyl cis-trans isomerase activity in a similar manner as human FKBP12. Previous studies revealed that the immunosuppressive drug FK506 exhibits potential anti-malarial activity by binding FK506 binding domains (FKBD). This review focuses on three different types of FK506 binding proteins/domains in pathogens, their structural characteristics and biological roles. Binding ability of these proteins with the macrolides has opened new possibilities to develop selective inhibitors for these novel targets to combat the life threatening infections.
dc.language.iso en
dc.relation.ispartofseries Current medicinal chemistry
dc.rights © 2011 Bentham Science Publishers.
dc.subject DRNTU::Science::Biological sciences::Microbiology::Bacteria
dc.title Targeting FK506 binding proteins to fight malarial and bacterial infections : current advances and future perspectives
dc.type Journal Article
dc.contributor.school School of Biological Sciences
dc.identifier.doi http://dx.doi.org/10.2174/092986711795496818

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record